MC2069A1 - Nouveaux composes antibacteriens - Google Patents

Nouveaux composes antibacteriens

Info

Publication number
MC2069A1
MC2069A1 MC892073A MC2073A MC2069A1 MC 2069 A1 MC2069 A1 MC 2069A1 MC 892073 A MC892073 A MC 892073A MC 2073 A MC2073 A MC 2073A MC 2069 A1 MC2069 A1 MC 2069A1
Authority
MC
Monaco
Prior art keywords
antibacterial compounds
new antibacterial
new
compounds
antibacterial
Prior art date
Application number
MC892073A
Other languages
English (en)
French (fr)
Inventor
Joseph Bartkovitz David
Dalton Keith Dennis
Mook Robert
Wei Chung-Chen
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MC2069A1 publication Critical patent/MC2069A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/21Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a nitrogen atom directly attached in position 6 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D499/44Compounds with an amino radical acylated by carboxylic acids, attached in position 6
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
MC892073A 1988-10-31 1989-10-30 Nouveaux composes antibacteriens MC2069A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US26516188A 1988-10-31 1988-10-31
US41618689A 1989-10-02 1989-10-02

Publications (1)

Publication Number Publication Date
MC2069A1 true MC2069A1 (fr) 1990-10-03

Family

ID=26951020

Family Applications (1)

Application Number Title Priority Date Filing Date
MC892073A MC2069A1 (fr) 1988-10-31 1989-10-30 Nouveaux composes antibacteriens

Country Status (16)

Country Link
EP (1) EP0367124A1 (ja)
JP (1) JPH02191283A (ja)
KR (1) KR900006345A (ja)
CN (1) CN1047504A (ja)
AU (1) AU4389289A (ja)
CA (1) CA2001642A1 (ja)
DK (1) DK538689A (ja)
FI (1) FI895162A0 (ja)
HU (1) HUT52102A (ja)
IL (1) IL92139A0 (ja)
MC (1) MC2069A1 (ja)
NO (1) NO894322L (ja)
OA (1) OA09142A (ja)
PT (1) PT92156A (ja)
TN (1) TNSN89120A1 (ja)
ZW (1) ZW13589A1 (ja)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69225821T2 (de) * 1991-03-13 1998-11-05 Otsuka Kagaku Kk Penamderivate und Verfahren zu deren Herstellung
SI2046802T1 (sl) * 2006-07-12 2014-03-31 Allecra Therapeutics Gmbh C/O Loeba Treuhand Gmbh 2-substituirani metil penamski derivati
US20110118462A1 (en) * 2009-11-18 2011-05-19 Guangzhou Baiyunshan Pharmaceutical Co., Ltd. Guangzhou Baiyunshan Pharmaceutical Factory N-heterocyclic substituent-containing antibiotic, preparation and use thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3466275A (en) * 1962-07-31 1969-09-09 Lilly Co Eli Modified penicillins and their preparation via penicillin sulfoxides
US3989685A (en) * 1972-06-29 1976-11-02 Shinogi & Co., Ltd. Process for making a 2'-halopenicillin
SE417968B (sv) * 1972-10-20 1981-04-27 Fujisawa Pharmaceutical Co Forfarande for framstellning av penamderivat
US4081443A (en) * 1976-01-29 1978-03-28 Shionogi & Co., Ltd. Penicillin oxides
GB1575415A (en) * 1976-12-31 1980-09-24 Connlab Holdings Ltd Process for preparing 2-acyloxymethyl-penams and 3-acloxycephams
US4322347A (en) * 1978-04-03 1982-03-30 Bristol-Myers Company 2-Carbamoyloxymethyl-penicillin derivatives
US4464237A (en) * 1982-08-09 1984-08-07 Otsuka Kagaku Yakuhin Kabushiki Kaisha Process for preparing β-lactam derivatives
EP0206000A1 (en) * 1985-06-01 1986-12-30 F. Hoffmann-La Roche Ag (2,3)-Alpha-methylenepenam-3-carboxylic acids and derivatives thereof
GB8709666D0 (en) * 1987-04-23 1987-05-28 Beecham Group Plc Compounds

Also Published As

Publication number Publication date
ZW13589A1 (en) 1990-06-13
PT92156A (pt) 1990-05-31
NO894322L (no) 1990-05-02
JPH02191283A (ja) 1990-07-27
HUT52102A (en) 1990-06-28
IL92139A0 (en) 1990-07-12
CN1047504A (zh) 1990-12-05
EP0367124A1 (en) 1990-05-09
OA09142A (fr) 1991-10-31
DK538689A (da) 1990-05-01
DK538689D0 (da) 1989-10-27
AU4389289A (en) 1990-05-03
CA2001642A1 (en) 1990-04-30
FI895162A0 (fi) 1989-10-31
KR900006345A (ko) 1990-05-08
TNSN89120A1 (fr) 1991-02-04
NO894322D0 (no) 1989-10-30

Similar Documents

Publication Publication Date Title
DK103389D0 (da) Forbedret braender
DK55889A (da) Substituerede pyrroler
IT1229451B (it) Mieti-trebbia
MA22407A1 (fr) Steroides-esters nouveaux
DK540389D0 (da) Immunstimulerende praeparat
TNSN92026A1 (fr) Nouveaux composes actifs
MC2262A1 (fr) Composes antibacteriens
DK296589D0 (da) Mikrobicid
MA20743A1 (fr) Composes nouveaux
FI89612B (fi) Anordning och foerfarande foer avlaegsnande av traoder
DK578389D0 (da) Substituerede oxadiaminobutaner
FI91488B (fi) Seula
PT8062U (pt) Oculos melhorados
DK99889D0 (da) Indlaeg
MC2069A1 (fr) Nouveaux composes antibacteriens
DK606288D0 (da) Praeparat
DE68928616D1 (de) Kodiereinrichtungsstruktur
DK429689A (da) Substituerede pyridazinoner
FI89615B (fi) Foerfarande foer framstaellning av ett pressband
DK343689A (da) Herbicidt praeparat
ATA296888A (de) Labyrinthanordnung
DK657289A (da) Antibakterielle forbindelser
FI934053A0 (fi) Antibakteriella aemnen
FI942505A0 (fi) Antibakteriella aemnen
MA21015A1 (fr) Nouveaux composes ecrans-solaires

Legal Events

Date Code Title Description
YP Annual fee paid